V Niemeier, J Kupfer, W-B Schill, U Gieler
Index: J. Dermatolog. Treat. 16(2) , 95-101, (2005)
Full Text: HTML
The treatment of atopic dermatitis still remains a challenge. Little research has been done on the issue of the extent to which patients correctly use prescribed topical preparations under everyday conditions.To investigate what quantity of topical preparations is applied by outpatients in daily routine treatment over a 26-week period and to what extent this consumption is related to the course of the severity of patients' skin conditions.Thirty adult outpatients (20 female and 10 male) with atopic dermatitis were examined at four different times during 26 weeks. For treatment and skin care these patients were given a topical glucocorticoid preparation (prednicarbate) and the corresponding emollient.The average severity rating (SCORAD) was 29.6 (before therapy 33.9, after 26 weeks 27.4). The SCORAD indices improved by a mean of 6.5 points (p<0.05).Patients who applied the correct amount of the prednicarbate-containing preparations (not less than 90% of 0.5 g/dm(2)) to the areas of affected skin showed a significant improvement in SCORAD indices across the four measuring times.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Prednicarbate
CAS:73771-04-7 |
C27H36O8 |
Cetuximab-induced skin exanthema: prophylactic and reactive ...
2013-10-01 [J. Cancer Res. Clin. Oncol. 139(10) , 1667-72, (2013)] |
Drug release and skin penetration from solid lipid nanoparti...
2011-01-01 [Skin Pharmacol. Physiol. 24(4) , 199-209, (2011)] |
Efficacy of crisis intervention treatment with topical corti...
2006-01-01 [Dermatology 212(1) , 66-9, (2006)] |
Transcriptional activity of potent glucocorticoids: relevanc...
2003-01-01 [Skin Pharmacol. Appl. Skin Physiol. 16(3) , 143-50, (2003)] |
Steroid-sparing effect of pimecrolimus cream 1% in children ...
2007-01-01 [Dermatology 215(4) , 325-30, (2007)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved